Average Co-Inventor Count = 7.82
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Revolution Medicines, Inc. (8 from 35 patents)
2. Sfunga Therapeutics, Inc. (3 from 3 patents)
3. Maze Therapeutics, Inc. (1 from 3 patents)
12 patents:
1. 12365688 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
2. 11814367 - Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof
3. 11739093 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
4. 11702411 - Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
5. 11673901 - Polycyclic compounds as allosteric SHP2 inhibitors
6. 11673896 - Pyridine compounds as allosteric SHP2 inhibitors
7. 11661401 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
8. 10980889 - C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
9. 10882883 - Derivatives of amphotericin B
10. 10597420 - Derivatives of amphotericin B
11. 10590090 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
12. 9957290 - Derivatives of amphotericin B